479 related articles for article (PubMed ID: 2878044)
1. Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes.
Kehrl JH; Roberts AB; Wakefield LM; Jakowlew S; Sporn MB; Fauci AS
J Immunol; 1986 Dec; 137(12):3855-60. PubMed ID: 2878044
[TBL] [Abstract][Full Text] [Related]
2. Further studies of the role of transforming growth factor-beta in human B cell function.
Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
[TBL] [Abstract][Full Text] [Related]
3. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA.
Kehrl JH; Thevenin C; Rieckmann P; Fauci AS
J Immunol; 1991 Jun; 146(11):4016-23. PubMed ID: 1903417
[TBL] [Abstract][Full Text] [Related]
5. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
Kumar A; Rogers T; Maizel A; Sharma S
J Immunol; 1991 Aug; 147(3):998-1006. PubMed ID: 1713611
[TBL] [Abstract][Full Text] [Related]
6. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function.
Rieckmann P; D'Alessandro F; Nordan RP; Fauci AS; Kehrl JH
J Immunol; 1991 May; 146(10):3462-8. PubMed ID: 2026875
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the proliferative response of human B lymphocytes to B cell growth factor by transforming growth factor-beta.
Petit-Koskas E; Génot E; Lawrence D; Kolb JP
Eur J Immunol; 1988 Jan; 18(1):111-6. PubMed ID: 3257917
[TBL] [Abstract][Full Text] [Related]
8. Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation.
Ehrhardt RO; Strober W; Harriman GR
J Immunol; 1992 Jun; 148(12):3830-6. PubMed ID: 1602131
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes.
Inge TH; McCoy KM; Susskind BM; Barrett SK; Zhao G; Bear HD
J Immunol; 1992 Jun; 148(12):3847-56. PubMed ID: 1602133
[TBL] [Abstract][Full Text] [Related]
10. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
Murakawa Y; Strober W; James SP
J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
[TBL] [Abstract][Full Text] [Related]
12. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD; Birnbaum LS
Cancer Res; 1989 Jun; 49(12):3196-202. PubMed ID: 2541899
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta down-regulates stromal IL-7 secretion and inhibits proliferation of human B cell precursors.
Tang J; Nuccie BL; Ritterman I; Liesveld JL; Abboud CN; Ryan DH
J Immunol; 1997 Jul; 159(1):117-25. PubMed ID: 9200446
[TBL] [Abstract][Full Text] [Related]
16. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.
Rook AH; Kehrl JH; Wakefield LM; Roberts AB; Sporn MB; Burlington DB; Lane HC; Fauci AS
J Immunol; 1986 May; 136(10):3916-20. PubMed ID: 2871107
[TBL] [Abstract][Full Text] [Related]
17. Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Ruegemer JJ; Ho SN; Augustine JA; Schlager JW; Bell MP; McKean DJ; Abraham RT
J Immunol; 1990 Mar; 144(5):1767-76. PubMed ID: 2407783
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
[TBL] [Abstract][Full Text] [Related]
19. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
